Terug
36
Dagbereik
€ 13,25
€ 13,57
52-Weeksbereik
€ 9,30
€ 15,68
Volume
555.712
50D / 200D Gem.
€ 13,60
/
€ 12,15
Vorige Slotkoers
€ 13,05
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,2 | 0,4 |
| P/B | 0,8 | 2,9 |
| ROE % | -8,5 | 3,8 |
| Net Margin % | -9,7 | 3,9 |
| Rev Growth 5Y % | -1,5 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 23,00
+71.6%
Low: € 20,00
High: € 26,00
Forward K/W
13,4
Forward WPA
€ 1,00
WPA Groei (sch.)
+0,0%
Omzet Sch.
710 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 1,25
€ 1,25 – € 1,25
|
740 M | 1 |
| FY2026 |
€ 1,00
€ 1,00 – € 1,00
|
710 M | 1 |
Belangrijkste Punten
Revenue declined -1,49% annually over 5 years
Debt/Equity of 0,17 — conservative balance sheet
Generating 43,10M in free cash flow
PEG of 0,09 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,44%
Capital efficient — spends only 4,51% of revenue on capex
Groei
Revenue Growth (5Y)
-1,49%
Revenue (1Y)1,95%
Earnings (1Y)N/A
FCF Growth (3Y)71,82%
Kwaliteit
Return on Equity
-8,45%
ROIC-5,09%
Net Margin-9,68%
Op. Margin-8,78%
Veiligheid
Debt / Equity
0,17
Current Ratio2,15
Interest Coverage-15,40
Waardering
P/E Ratio
-9,18
P/B Ratio0,80
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,95% | Revenue Growth (3Y) | 2,05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1,49% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 701,20M | Net Income (TTM) | -67,90M |
| ROE | -8,45% | ROA | -6,32% |
| Gross Margin | 49,77% | Operating Margin | -8,78% |
| Net Margin | -9,68% | Free Cash Flow (TTM) | 43,10M |
| ROIC | -5,09% | FCF Growth (3Y) | 71,82% |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 2,15 |
| Interest Coverage | -15,40 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,18 | P/B Ratio | 0,80 |
| P/S Ratio | 0,89 | PEG Ratio | 0,09 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 623,15M | Enterprise Value | 662,45M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 701,20M | 687,80M | 673,30M | 684,10M | 744,60M |
| Net Income | -67,90M | -392,10M | -61,80M | 50,50M | 6,30M |
| EPS (Diluted) | -1,46 | -8,53 | -1,33 | 1,07 | 0,13 |
| Gross Profit | 349,00M | 381,30M | 379,70M | 394,20M | 379,90M |
| Operating Income | -61,60M | 40,00M | 65,00M | 41,90M | 86,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,07B | 1,15B | 1,69B | 1,79B | 1,60B |
| Total Liabilities | 295,50M | 325,70M | 456,10M | 495,70M | 333,00M |
| Shareholders' Equity | 778,20M | 828,50M | 1,24B | 1,29B | 1,27B |
| Total Debt | 129,10M | 170,20M | 209,10M | 277,00M | 187,50M |
| Cash & Equivalents | 89,80M | 107,70M | 87,70M | 127,70M | 118,50M |
| Current Assets | 355,40M | 393,40M | 487,00M | 624,10M | 427,60M |
| Current Liabilities | 165,20M | 165,90M | 234,60M | 191,00M | 139,20M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#503 of 820
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026